125 results
Page 6 of 7
424B3
iccjy4vhc1y2ggrzehq
26 Oct 15
Prospectus supplement
12:00am
424B3
xm75j567dyizo0kuv q1
10 Apr 15
Prospectus supplement
12:00am
10-K
883zxzzkoeez
25 Mar 15
Annual report
12:00am
424B3
jt2fn 8anzlz716
26 Feb 15
Prospectus supplement
12:00am
8-K
EX-10.1
dyquc0o4azqw 4dwi60
3 Feb 15
Recro Pharma Enters into Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
EX-99.1
8pd42f
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.2
v2uypzpfa8htyera401q
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
x5e5yhdumrrrxlzix 5z
30 Oct 14
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
12:00am
8-K
EX-99.2
w4fg1 1gkpb
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
EX-99.1
uwms5rc4aqq0e6yddg6
12 Aug 14
Recro Pharma Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
va32uzsr6p
17 Jun 14
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
12:00am
8-K
EX-99.1
6wjxg1nhl0e 6v8ui36
1 Apr 14
This presentation includes forward-looking statements within the meaning of Section
12:00am
424B4
5d3y1z71al2nd8o6o9a
7 Mar 14
Prospectus supplement with pricing info
12:00am
S-1/A
EX-10.1
avrdxcbivg
29 Nov 13
IPO registration (amended)
12:00am